S206: ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT

Detalles Bibliográficos
Autores principales: Hartmann, Mark, Schönung, Maximilian, Rajak, Jovana, Hey, Joschka, Maurer, Valentin, Hai, Ling, Staeble, Sina, Langstein, Jens, Bauer, Katharina, Hakobyan, Mariam, Jardine, Laura, Bohler, Sheila, Vonficht, Dominik, Maag, Abdul-Habib, Lebrecht, Dirk, Bernt, Kathrin, Rölz, Roland, Boch, Tobias, Khabirova, Eleonora, Lutsik, Pavlo, Haas, Simon, Haniffa, Muzlifah, Behjati, Sam, Mallm, Jan-Philipp, Buske, Christian, Milsom, Michael, Fröhling, Stefan, Bonder, Marc-Jan, Plass, Christoph, Niemeyer, Charlotte, Flotho, Christian, Erlacher, Miriam, Schlesner, Matthias, Lipka, Daniel B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Oral Sessions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428423/
http://dx.doi.org/10.1097/01.HS9.0000967736.39273.98

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428423/
http://dx.doi.org/10.1097/01.HS9.0000967736.39273.98

Ejemplares similares